NAMS MENOPAUSE CERTIFICATION ACTUAL EXAM
[QUESTION 1- 200] AND ANSWERS UPDATED 2026/2027| 100%
VERIFIED|DETAILED RATIONALES –PASS GUARANTEED
A+ GRADED |INSTANT DOWNLOAD
INTRODUCTION
The current certification formerly associated with the North American Menopause Society
(NAMS) is the The Menopause Society Certified Practitioner (MSCP) credential,
administered by The Menopause Society. The 2026 MSCP competency examination is designed
to assess clinically relevant knowledge and decision-making in menopause and midlife women's
health. The Society states that the examination was developed from a national role-delineation
study and is linked to the activities considered important to competent menopause practice.
Eligibility is open to licensed healthcare professionals, including nurses, nurse midwives, nurse
practitioners, pharmacists, physicians, and physician assistants, with documentation of current
licensure required. The credential is intended for clinicians who evaluate and manage
menopause-related symptoms, preventive health concerns, and diseases affecting midlife women.
Certification provides professional recognition of demonstrated competency in menopause care
and may support professional credibility, referrals, and career development. The credential is
valid for three years under the current program, with maintenance available through qualifying
continuing education or reexamination. (The Menopause Society)
The actual 2026 MSCP examination contains 100 multiple-choice questions with three
response alternatives (A, B, C) and allows 2 hours. It is administered in English, primarily
through live remote proctoring, with in-person testing available at designated centers. The
current examination is organized across five major content areas. The 200 questions below are
original practice questions—not disclosed or reproduced actual examination questions—
and use four choices as requested.
Core Domains Tested in NAMS Menopause Certification
Physiology/Pathophysiology of the Menopause Transition
Symptoms and Concerns
Health Disorders in Midlife
Treatment Options for Common Menopause Symptoms
Preventive Care and Counseling
Hormone therapy and nonhormone treatment
Genitourinary, sexual, pelvic-floor, cognitive, and mood health
Cardiovascular, thromboembolic, metabolic, cancer, and bone health
Immunizations and sexually transmitted infection prevention
Psychosocial health, diet, exercise, and risk reduction
,CONTENT AREA TABLE
% of Approx. # of
Content Domain Key Topics Covered
Exam Questions
Menopause definitions, STRAW,
Physiology/Pathophysiology of the
19% 19 ovarian aging, POI, surgical
Menopause Transition
menopause
VMS, GSM, sexual health, sleep,
Symptoms and Concerns 20% 20
bleeding, cognition, pelvic floor
Thyroid, headache, mood, CVD,
Health Disorders in Midlife 21% 21 thrombosis, diabetes, cancer,
osteoporosis
Hormone therapy, nonhormone
Treatment Options for Common
21% 21 therapy, OTC therapies,
Menopause Symptoms
complementary approaches
Immunizations, STI prevention,
Preventive Care and Counseling 19% 19 psychosocial screening, diet,
exercise
All major MSCP competency
Total 100% 100
domains
The percentages above follow the 2026 Candidate Handbook content outline.
QUESTIONS 1-200
Q1: A 47-year-old woman reports increasingly irregular cycles, occasional skipped months,
and new hot flashes. She has not had 12 consecutive months without menstruation. Which
term most accurately describes her current reproductive stage?
A) Postmenopause
B) Menopause transition
C) Menopause
D) Primary ovarian insufficiency
Correct Answer: B
Rationale: The menopause transition is the interval leading up to the final menstrual period and
is characterized by changing cycle length and increasing hormonal variability. Menopause is
diagnosed retrospectively after 12 months of amenorrhea when no other cause is identified.
Postmenopause follows menopause. Primary ovarian insufficiency generally refers to loss of
ovarian function before age 40.
Q2: A 51-year-old has experienced 14 months of amenorrhea with no alternative cause
identified. Which event establishes the clinical diagnosis of natural menopause?
A) FSH exceeding 20 IU/L
B) Twelve consecutive months without menstruation
,C) Estradiol below 50 pg/mL
D) Onset of vasomotor symptoms
Correct Answer: B
Rationale: Natural menopause is diagnosed clinically after 12 consecutive months of
amenorrhea in an appropriate clinical setting. FSH and estradiol measurements are generally
unnecessary for diagnosing menopause in typical women over 45. Vasomotor symptoms support
the history but do not define menopause.
Q3: A 39-year-old has had irregular menses for 10 months and repeated FSH elevations
consistent with ovarian insufficiency. Which diagnosis should be considered most strongly?
A) Normal postmenopause
B) Late reproductive aging
C) Primary ovarian insufficiency
D) Physiologic menopause
Correct Answer: C
Rationale: Primary ovarian insufficiency involves impaired ovarian function occurring before
age 40 and may present with irregular or absent menses and biochemical evidence of ovarian
insufficiency. It differs from normal menopause, which usually occurs later. Evaluation should
also exclude pregnancy and other causes of amenorrhea.
Q4: A woman with an intact uterus undergoes bilateral oophorectomy at age 44 for a
benign condition. Which immediate endocrine consequence is most likely?
A) Gradual decline in ovarian estrogen over several years
B) Abrupt loss of ovarian estrogen production
C) Increased ovarian progesterone secretion
D) Persistent cyclic ovulation
Correct Answer: B
Rationale: Bilateral oophorectomy produces surgical menopause because ovarian estrogen
production falls abruptly. This contrasts with natural menopause, where ovarian function
declines progressively. Early estrogen loss has implications for vasomotor symptoms, bone,
cardiovascular, genitourinary, and overall health.
Q5: A 36-year-old with primary ovarian insufficiency asks whether hormone therapy is
appropriate even though she has few hot flashes. Which counseling point is most
appropriate?
A) Hormone therapy should never be used before age 50
B) Treatment is indicated only for severe vasomotor symptoms
C) Hormone therapy is generally considered until the usual age of menopause unless
contraindicated
D) Hormone therapy should be avoided because POI carries no long-term health consequences
Correct Answer: C
Rationale: POI results in prolonged estrogen deficiency at an unusually young age. In the
absence of contraindications, systemic hormone therapy is generally recommended until
approximately the average age of natural menopause to address consequences of early estrogen
loss, including bone and cardiovascular health. The decision remains individualized.
, Q6: A 46-year-old with irregular cycles experiences a sudden episode of heavy bleeding
after several months of infrequent menses. Which mechanism commonly contributes to
bleeding variability during the menopause transition?
A) Consistently high progesterone secretion
B) Anovulatory cycles associated with fluctuating ovarian function
C) Permanent suppression of endometrial estrogen receptors
D) Complete absence of endometrial proliferation
Correct Answer: B
Rationale: During the menopause transition, ovulatory dysfunction becomes increasingly
common. Periods of estrogen exposure without adequate progesterone opposition can result in
variable endometrial proliferation and unpredictable bleeding. Heavy or abnormal bleeding still
requires appropriate evaluation based on age and clinical circumstances.
Q7: A 48-year-old has a normal menstrual period followed by an unusually short cycle and
then a prolonged interval without bleeding. She asks why her symptoms fluctuate so
dramatically. Which physiologic phenomenon best explains this variability?
A) Permanent cessation of ovarian follicular activity
B) Marked hormonal variability during late reproductive aging
C) Stable high progesterone concentrations
D) Continuous ovulation throughout the transition
Correct Answer: B
Rationale: The menopause transition is characterized by substantial variability in follicular
function and hormone production. Ovulation may become intermittent, and estrogen
concentrations can fluctuate considerably. This explains changing bleeding patterns and
episodic symptoms.
Q8: A 49-year-old reports hot flashes that occur primarily during months when her cycles
become irregular. Which neurotransmitter-related mechanism is most closely associated
with vasomotor symptoms?
A) Excess acetylcholine from the adrenal cortex
B) Altered hypothalamic thermoregulatory signaling involving kisspeptin/neurokinin B
pathways
C) Increased pancreatic insulin secretion
D) Suppression of hypothalamic norepinephrine
Correct Answer: B
Rationale: Vasomotor symptoms are linked to changes in hypothalamic thermoregulation
associated with reproductive hormone withdrawal and altered neurokinin B signaling. The
thermoneutral zone becomes narrower, allowing small changes in core temperature to trigger
heat-dissipation responses.
Q9: A 45-year-old with chemotherapy-associated amenorrhea asks whether her ovarian
function can ever recover. Which statement is most accurate?
A) Chemotherapy-induced ovarian dysfunction is always permanent
B) Menstrual recovery guarantees normal fertility
C) Ovarian recovery varies according to age, treatment, and gonadotoxic exposure
D) Ovarian reserve is unaffected if menses return
[QUESTION 1- 200] AND ANSWERS UPDATED 2026/2027| 100%
VERIFIED|DETAILED RATIONALES –PASS GUARANTEED
A+ GRADED |INSTANT DOWNLOAD
INTRODUCTION
The current certification formerly associated with the North American Menopause Society
(NAMS) is the The Menopause Society Certified Practitioner (MSCP) credential,
administered by The Menopause Society. The 2026 MSCP competency examination is designed
to assess clinically relevant knowledge and decision-making in menopause and midlife women's
health. The Society states that the examination was developed from a national role-delineation
study and is linked to the activities considered important to competent menopause practice.
Eligibility is open to licensed healthcare professionals, including nurses, nurse midwives, nurse
practitioners, pharmacists, physicians, and physician assistants, with documentation of current
licensure required. The credential is intended for clinicians who evaluate and manage
menopause-related symptoms, preventive health concerns, and diseases affecting midlife women.
Certification provides professional recognition of demonstrated competency in menopause care
and may support professional credibility, referrals, and career development. The credential is
valid for three years under the current program, with maintenance available through qualifying
continuing education or reexamination. (The Menopause Society)
The actual 2026 MSCP examination contains 100 multiple-choice questions with three
response alternatives (A, B, C) and allows 2 hours. It is administered in English, primarily
through live remote proctoring, with in-person testing available at designated centers. The
current examination is organized across five major content areas. The 200 questions below are
original practice questions—not disclosed or reproduced actual examination questions—
and use four choices as requested.
Core Domains Tested in NAMS Menopause Certification
Physiology/Pathophysiology of the Menopause Transition
Symptoms and Concerns
Health Disorders in Midlife
Treatment Options for Common Menopause Symptoms
Preventive Care and Counseling
Hormone therapy and nonhormone treatment
Genitourinary, sexual, pelvic-floor, cognitive, and mood health
Cardiovascular, thromboembolic, metabolic, cancer, and bone health
Immunizations and sexually transmitted infection prevention
Psychosocial health, diet, exercise, and risk reduction
,CONTENT AREA TABLE
% of Approx. # of
Content Domain Key Topics Covered
Exam Questions
Menopause definitions, STRAW,
Physiology/Pathophysiology of the
19% 19 ovarian aging, POI, surgical
Menopause Transition
menopause
VMS, GSM, sexual health, sleep,
Symptoms and Concerns 20% 20
bleeding, cognition, pelvic floor
Thyroid, headache, mood, CVD,
Health Disorders in Midlife 21% 21 thrombosis, diabetes, cancer,
osteoporosis
Hormone therapy, nonhormone
Treatment Options for Common
21% 21 therapy, OTC therapies,
Menopause Symptoms
complementary approaches
Immunizations, STI prevention,
Preventive Care and Counseling 19% 19 psychosocial screening, diet,
exercise
All major MSCP competency
Total 100% 100
domains
The percentages above follow the 2026 Candidate Handbook content outline.
QUESTIONS 1-200
Q1: A 47-year-old woman reports increasingly irregular cycles, occasional skipped months,
and new hot flashes. She has not had 12 consecutive months without menstruation. Which
term most accurately describes her current reproductive stage?
A) Postmenopause
B) Menopause transition
C) Menopause
D) Primary ovarian insufficiency
Correct Answer: B
Rationale: The menopause transition is the interval leading up to the final menstrual period and
is characterized by changing cycle length and increasing hormonal variability. Menopause is
diagnosed retrospectively after 12 months of amenorrhea when no other cause is identified.
Postmenopause follows menopause. Primary ovarian insufficiency generally refers to loss of
ovarian function before age 40.
Q2: A 51-year-old has experienced 14 months of amenorrhea with no alternative cause
identified. Which event establishes the clinical diagnosis of natural menopause?
A) FSH exceeding 20 IU/L
B) Twelve consecutive months without menstruation
,C) Estradiol below 50 pg/mL
D) Onset of vasomotor symptoms
Correct Answer: B
Rationale: Natural menopause is diagnosed clinically after 12 consecutive months of
amenorrhea in an appropriate clinical setting. FSH and estradiol measurements are generally
unnecessary for diagnosing menopause in typical women over 45. Vasomotor symptoms support
the history but do not define menopause.
Q3: A 39-year-old has had irregular menses for 10 months and repeated FSH elevations
consistent with ovarian insufficiency. Which diagnosis should be considered most strongly?
A) Normal postmenopause
B) Late reproductive aging
C) Primary ovarian insufficiency
D) Physiologic menopause
Correct Answer: C
Rationale: Primary ovarian insufficiency involves impaired ovarian function occurring before
age 40 and may present with irregular or absent menses and biochemical evidence of ovarian
insufficiency. It differs from normal menopause, which usually occurs later. Evaluation should
also exclude pregnancy and other causes of amenorrhea.
Q4: A woman with an intact uterus undergoes bilateral oophorectomy at age 44 for a
benign condition. Which immediate endocrine consequence is most likely?
A) Gradual decline in ovarian estrogen over several years
B) Abrupt loss of ovarian estrogen production
C) Increased ovarian progesterone secretion
D) Persistent cyclic ovulation
Correct Answer: B
Rationale: Bilateral oophorectomy produces surgical menopause because ovarian estrogen
production falls abruptly. This contrasts with natural menopause, where ovarian function
declines progressively. Early estrogen loss has implications for vasomotor symptoms, bone,
cardiovascular, genitourinary, and overall health.
Q5: A 36-year-old with primary ovarian insufficiency asks whether hormone therapy is
appropriate even though she has few hot flashes. Which counseling point is most
appropriate?
A) Hormone therapy should never be used before age 50
B) Treatment is indicated only for severe vasomotor symptoms
C) Hormone therapy is generally considered until the usual age of menopause unless
contraindicated
D) Hormone therapy should be avoided because POI carries no long-term health consequences
Correct Answer: C
Rationale: POI results in prolonged estrogen deficiency at an unusually young age. In the
absence of contraindications, systemic hormone therapy is generally recommended until
approximately the average age of natural menopause to address consequences of early estrogen
loss, including bone and cardiovascular health. The decision remains individualized.
, Q6: A 46-year-old with irregular cycles experiences a sudden episode of heavy bleeding
after several months of infrequent menses. Which mechanism commonly contributes to
bleeding variability during the menopause transition?
A) Consistently high progesterone secretion
B) Anovulatory cycles associated with fluctuating ovarian function
C) Permanent suppression of endometrial estrogen receptors
D) Complete absence of endometrial proliferation
Correct Answer: B
Rationale: During the menopause transition, ovulatory dysfunction becomes increasingly
common. Periods of estrogen exposure without adequate progesterone opposition can result in
variable endometrial proliferation and unpredictable bleeding. Heavy or abnormal bleeding still
requires appropriate evaluation based on age and clinical circumstances.
Q7: A 48-year-old has a normal menstrual period followed by an unusually short cycle and
then a prolonged interval without bleeding. She asks why her symptoms fluctuate so
dramatically. Which physiologic phenomenon best explains this variability?
A) Permanent cessation of ovarian follicular activity
B) Marked hormonal variability during late reproductive aging
C) Stable high progesterone concentrations
D) Continuous ovulation throughout the transition
Correct Answer: B
Rationale: The menopause transition is characterized by substantial variability in follicular
function and hormone production. Ovulation may become intermittent, and estrogen
concentrations can fluctuate considerably. This explains changing bleeding patterns and
episodic symptoms.
Q8: A 49-year-old reports hot flashes that occur primarily during months when her cycles
become irregular. Which neurotransmitter-related mechanism is most closely associated
with vasomotor symptoms?
A) Excess acetylcholine from the adrenal cortex
B) Altered hypothalamic thermoregulatory signaling involving kisspeptin/neurokinin B
pathways
C) Increased pancreatic insulin secretion
D) Suppression of hypothalamic norepinephrine
Correct Answer: B
Rationale: Vasomotor symptoms are linked to changes in hypothalamic thermoregulation
associated with reproductive hormone withdrawal and altered neurokinin B signaling. The
thermoneutral zone becomes narrower, allowing small changes in core temperature to trigger
heat-dissipation responses.
Q9: A 45-year-old with chemotherapy-associated amenorrhea asks whether her ovarian
function can ever recover. Which statement is most accurate?
A) Chemotherapy-induced ovarian dysfunction is always permanent
B) Menstrual recovery guarantees normal fertility
C) Ovarian recovery varies according to age, treatment, and gonadotoxic exposure
D) Ovarian reserve is unaffected if menses return
